Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Identification for Bladder Cancer Patients

NCT02053662 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT02053662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02053662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Identification for Bladder Cancer Patients
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Observational
Overall status
Terminated
Start date
January 21, 2014
Completion date
November 16, 2023
Enrollment
179 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer